Recent News

• 08.14.2025 - Daré Bioscience, Inc. Q2 2025 Conference Call
• 08.14.2025 - Daré Bioscience, Inc. Q2 2025 Conference Call
• 08.14.2025 - Daré Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate Update
• 08.14.2025 - Daré Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate Update
• 08.07.2025 - Daré Bioscience to Host Second Quarter 2025 Financial Results and Company Update Conference Call and Webcast on August 14, 2025
• 08.07.2025 - Daré Bioscience to Host Second Quarter 2025 Financial Results and Company Update Conference Call and Webcast on August 14, 2025
• 08.06.2025 - The DARE to PLAY™ Difference
• 08.06.2025 - The DARE to PLAY™ Difference
• 07.29.2025 - Daré Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY™ Sildenafil Cream
• 07.29.2025 - Daré Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY™ Sildenafil Cream

Recent Filings

• 08.14.2025 - EX-99.1 EX-99.1
• 08.14.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 08.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.14.2025 - 8-K Current report
• 07.25.2025 - 8-K Current report
• 07.21.2025 - 8-K Current report